A threshold mechanism mediates p53 cell fate decision between growth arrest and apoptosis.

Live or let die: the cell's response to p53

Vousden, K. H., & Lü, X. (2002) · Nature reviews. Cancer · doi:10.1038/nrc864 · Cited by 3,177 · see citing works

Blinded by the Light: The Growing Complexity of p53

Vousden, K. H., & Prives, C. (2009) · Cell · doi:10.1016/j.cell.2009.04.037 · Cited by 3,163 · see citing works

p53 in health and disease

Vousden, K. H., & Lane, D. P. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2147 · Cited by 2,275 · see citing works

ABT-263: A Potent and Orally Bioavailable Bcl-2 Family Inhibitor

Tse, C., Shoemaker, A. R., Adickes, J., Anderson, M. G., Chen, J., Jin, S., Johnson, E. F., Marsh, K. C., Mitten, M. J., Nimmer, P., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5836 · Cited by 1,992 · see citing works

Transcriptional control of human p53-regulated genes

Riley, T., Sontag, E., Chen, P., & Levine, A. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2395 · Cited by 1,921 · see citing works

γH2AX and cancer

Bonner, W. M., Redon, C. E., Dickey, J. S., Nakamura, A. J., Sedelnikova, O. A., Solier, S., & Pommier, Y. (2008) · Nature reviews. Cancer · doi:10.1038/nrc2523 · Cited by 1,623 · see citing works

Intrinsic tumour suppression

Lowe, S. W., Cepero, E., & Evan, G. I. (2004) · Nature · doi:10.1038/nature03098 · Cited by 1,309 · see citing works

Regulating the p53 pathway: in vitro hypotheses, in vivo veritas

Toledo, F., & Wahl, G. M. (2006) · Nature reviews. Cancer · doi:10.1038/nrc2012 · Cited by 1,286 · see citing works

Decision making by p53: life, death and cancer

Oren, M. (2003) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401183 · Cited by 1,063 · see citing works

Non-genetic origins of cell-to-cell variability in TRAIL-induced apoptosis

Spencer, S. L., Gaudet, S., Albeck, J. G., Burke, J. M., & Sorger, P. K. (2009) · Nature · doi:10.1038/nature08012 · Cited by 1,023 · see citing works

Awakening guardian angels: drugging the p53 pathway

Brown, C. J., Lain, S., Verma, C. S., Fersht, A. R., & Lane, D. P. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2763 · Cited by 881 · see citing works

p53 levels, functional domains, and DNA damage determine the extent of the apoptotic response of tumor cells.

Chen, X., Ko, L. J., Jayaraman, L., & Prives, C. (1996) · Genes & Development · doi:10.1101/gad.10.19.2438 · Cited by 735 · see citing works

Small-molecule MDM2 antagonists reveal aberrant p53 signaling in cancer: implications for therapy

Tovar, C., Rosinski, J., Filipovic, Z., Higgins, B., Kolinsky, K., Hilton, H., Zhao, X., Vu, B. T., Qing, W., Packman, K., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507493103 · Cited by 708 · see citing works

NPAT links cyclin E–Cdk2 to the regulation of replication-dependent histone gene transcriptionPreprint

Zhao, J., Kennedy, B. K., Lawrence, B. D., Barbie, D. A., Matera, A. G., Fletcher, J. A., & Harlow, E. (2000) · Genes & Development · doi:10.1101/gad.827700 · Cited by 665 · see citing works

Analysis of p53-regulated gene expression patterns using oligonucleotide arraysPreprint

Zhao, R., Gish, K., Murphy, M. E., Yin, Y., Notterman, D. A., Hoffman, W. H., Tom, E., Mack, D. H., & Levine, A. J. (2000) · Genes & Development · doi:10.1101/gad.14.8.981 · Cited by 631 · see citing works

Coping with stress: multiple ways to activate p53

Horn, H. F., & Vousden, K. H. (2007) · Oncogene · doi:10.1038/sj.onc.1210263 · Cited by 522 · see citing works

p53 and E2f: partners in life and death

Polager, S., & Ginsberg, D. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2718 · Cited by 498 · see citing works

Dose-dependent oncogene-induced senescence in vivo and its evasion during mammary tumorigenesis

Sarkisian, C. J., Keister, B. A., Stairs, D. B., Boxer, R. B., Moody, S. E., & Chodosh, L. A. (2007) · Nature Cell Biology · doi:10.1038/ncb1567 · Cited by 490 · see citing works

Distinct Thresholds Govern Myc's Biological Output In Vivo

Murphy, D. J., Junttila, M. R., Pouyet, L., Karnezis, A., Shchors, K., Bui, D. A., Brown-Swigart, L., Johnson, L., & Evan, G. I. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.10.018 · Cited by 456 · see citing works

High-Intensity Raf Signal Causes Cell Cycle Arrest Mediated by p21 Cip1

Sewing, A., Wiseman, B. S., Lloyd, A. C., & Land, H. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.9.5588 · Cited by 455 · see citing works

A complex barcode underlies the heterogeneous response of p53 to stress

Murray-Zmijewski, F., Slee, E. A., & Lu, X. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2451 · Cited by 420 · see citing works

Induction of transformation and continuous cell lines from normal human mammary epithelial cells after exposure to benzo[a]pyrene.

Stampfer, M. R., & Bartley, J. C. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.8.2394 · Cited by 414 · see citing works

Translating p53 into the clinic

Cheok, C. F., Verma, C. S., Baselga, J., & Lane, D. P. (2011) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2010.174 · Cited by 381 · see citing works

The p53–Bcl-2 connection

Hemann, M. T., & Lowe, S. W. (2006) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401962 · Cited by 370 · see citing works

Chromatin immunoprecipitation analysis fails to support the latency model for regulation of p53 DNA binding activity in vivo

Kaeser, M., & Iggo, R. (2001) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.012283399 · Cited by 346 · see citing works

Measuring and Modeling Apoptosis in Single Cells

Spencer, S. L., & Sorger, P. K. (2011) · Cell · doi:10.1016/j.cell.2011.03.002 · Cited by 333 · see citing works

Influence of Induced Reactive Oxygen Species in p53-Mediated Cell Fate Decisions

Macip, S., Igarashi, M., Berggren, P., Yu, J., Lee, S. W., & Aaronson, S. A. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.23.8576-8585.2003 · Cited by 331 · see citing works

Mathematical modeling reveals threshold mechanism in CD95-induced apoptosis

Bentele, M., Lavrik, I. N., Ulrich, M., Stößer, S., Heermann, D. W., Kalthoff, H., Krammer, P. H., & Eils, R. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200404158 · Cited by 311 · see citing works

Structure-Based Design of Potent Small-Molecule Inhibitors of Anti-Apoptotic Bcl-2 Proteins

Wang, G., Nikolovska‐Coleska, Z., Yang, C., Wang, R., Tang, G., Guo, J., Shangary, S. K., Qiu, S., Gao, W., Yang, D., et al. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm060460o · Cited by 293 · see citing works

A polymorphic microsatellite that mediates induction of PIG3 by p53

Contente, A., Dittmer, A., Koch, M. C., Roth, J., & Dobbelstein, M. (2002) · Nature Genetics · doi:10.1038/ng836 · Cited by 274 · see citing works

Nuclear Translocation of Caspase-3 Is Dependent on Its Proteolytic Activation and Recognition of a Substrate-like Protein(s)

Kamada, S., Kikkawa, U., Tsujimoto, Y., & Hunter, T. R. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.c400538200 · Cited by 257 · see citing works

Mdm2 is critically and continuously required to suppress lethal p53 activity in vivo

Ringshausen, I., O'Shea, C. C., Finch, A. J., Swigart, L. B., & Evan, G. I. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.10.010 · Cited by 256 · see citing works

Growth suppression induced by wild-type p53 protein is accompanied by selective down-regulation of proliferating-cell nuclear antigen expression.

Mercer, W. E., Shields, M. T., Lin, D. P., Appella, E., & Ullrich, S. J. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.5.1958 · Cited by 248 · see citing works

Global transcriptional program of p53 target genes during the process of apoptosis and cell cycle progression

Mirza, A., Wu, Q. J., Wang, L., McClanahan, T., Bishop, W. R., Gheyas, F., Ding, W., Hutchins, B., Hockenberry, T., Kirschmeier, P. T., et al. (2003) · Oncogene · doi:10.1038/sj.onc.1206477 · Cited by 183 · see citing works

Kinetics of p53 Binding to Promoter Sites In Vivo

Szak, S. T., Mays, D. J., & Pietenpol, J. A. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.10.3375-3386.2001 · Cited by 178 · see citing works

p53 Is Preferentially Recruited to the Promoters of Growth Arrest Genes p21 and GADD45 during Replicative Senescence of Normal Human Fibroblasts

Jackson, J. G., & Pereira‐Smith, O. M. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1752 · Cited by 165 · see citing works

Wnt pathway aberrations including autocrine Wnt activation occur at high frequency in human non-small-cell lung carcinoma

Akiri, G., Cherian, M. M., Vijayakumar, S., Liu, G., Bafico, A., & Aaronson, S. A. (2009) · Oncogene · doi:10.1038/onc.2009.82 · Cited by 143 · see citing works

p53-regulated Transcriptional Program Associated with Genotoxic Stress-induced Apoptosis

Kho, P. S., Wang, Z., Zhuang, L., Li, Y., Chew, J.-L., Ng, H., Liu, E. T., & Yu, Q. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311912200 · Cited by 143 · see citing works

Ablation of Key Oncogenic Pathways by RITA-Reactivated p53 Is Required for Efficient Apoptosis

Grinkevich, V. V., Nikulenkov, F., Shi, Y., Enge, M., Bao, W., Malyukova, A., Gluch, A., Kel, A. E., Sangfelt, O., & Selivanova, G. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.03.021 · Cited by 118 · see citing works

Multiple distinct molecular mechanisms influence sensitivity and resistance to MDM2 inhibitors in adult acute myelogenous leukemia

Long, J., Parkin, B. L., Ouillette, P. D., Bixby, D. L., Shedden, K., Erba, H. P., Wang, S., & Malek, S. N. (2010) · Blood · doi:10.1182/blood-2010-01-261628 · Cited by 85 · see citing works

Transcriptional profiling of MCF7 breast cancer cells in response to 5‐Fluorouracil: Relationship with cell cycle changes and apoptosis, and identification of novel targets of p53

Hernández‐Vargas, H., Ballestar, E., Carmona‐Sáez, P., von Kobbe, C., Bañón‐Rodríguez, I., Esteller, M., Moreno‐Bueno, G., & Palacios, J. (2006) · International Journal of Cancer · doi:10.1002/ijc.21938 · Cited by 81 · see citing works

Rethinking clinical trials for cytostatic drugs

Millar, A. W., & Lynch, K. (2003) · Nature reviews. Cancer · doi:10.1038/nrc1124 · Cited by 72 · see citing works

p21 does not protect cancer cells from apoptosis induced by nongenotoxic p53 activation

Xia, M., Knezevic, D., & Vassilev, L. T. (2011) · Oncogene · doi:10.1038/onc.2010.413 · Cited by 64 · see citing works

Regulation of tissue‐ and stimulus‐specific cell fate decisions by p53 in vivo

Jackson, J. G., Post, S. M., & Lozano, G. (2010) · The Journal of Pathology · doi:10.1002/path.2783 · Cited by 54 · see citing works

p53 Mediates Repression of the BRCA2 Promoter and Down-regulation of BRCA2 mRNA and Protein Levels in Response to DNA Damage

Wu, K., Jiang, S. W., & Couch, F. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211297200 · Cited by 50 · see citing works

Global Genechip Profiling to Identify Genes Responsive to p53-Induced Growth Arrest and Apoptosis in Human Lung Carcinoma Cells

Robinson, M., Jiang, P., Cui, J., Li­, ­., Wang, Y., Swaroop, M., Madore, S., Lawrence, T. S., & Sun, Y. (2003) · Cancer Biology & Therapy · doi:10.4161/cbt.2.4.437 · Cited by 41 · see citing works

Double Bolt Regulation of Rad51 by p53: A Role for Transcriptional Repression

Lazaro‐Trueba, I., Arias, C., & Silva, A. (2006) · Cell Cycle · doi:10.4161/cc.5.10.2764 · Cited by 28 · see citing works

Treatment with a BH3 mimetic overcomes the resistance of latency III EBV (+) cells to p53-mediated apoptosis

Pujals, A., Renouf, B., Robert, A., Chelouah, S., Hollville, É., & Wiels, J. (2011) · Cell Death and Disease · doi:10.1038/cddis.2011.67 · Cited by 17 · see citing works

Characterization of Adriamycin-Induced G2 Arrest and Its Abrogation by Caffeine in FL-Amnion Cells with or without p53

Minemoto, Y., Gannon, J., Masutani, M., Nakagama, H., Sasagawa, T., Inoue, M., Masamune, Y., & Yamashita, K. (2001) · Experimental Cell Research · doi:10.1006/excr.2000.5072 · Cited by 16 · see citing works

The multiple mechanisms that regulate p53 activity and cell fate

Hafner, A., Bulyk, M. L., Jambhekar, A., & Lahav, G. (2019) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-019-0110-x · Cited by 1,129 · see citing works

P53 in survival, death and metabolic health: a lifeguard with a licence to kill.

Kruiswijk, F., Labuschagne, C. F., & Vousden, K. H. (2015) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm4007 · Cited by 1,080 · see citing works

Drugging the p53 pathway: understanding the route to clinical efficacy

Khoo, K. H., Verma, C. S., & Lane, D. P. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4236 · Cited by 723 · see citing works

Integration of TP53, DREAM, MMB-FOXM1 and RB-E2F target gene analyses identifies cell cycle gene regulatory networks

Fischer, M., Grossmann, P., Padi, M., & DeCaprio, J. A. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw523 · Cited by 330 · see citing works

Clinical Overview of MDM2/X-Targeted Therapies

Burgess, A., Chia, K. M., Haupt, S., Thomas, D., Haupt, Y., & Lim, E. (2016) · Frontiers in Oncology · doi:10.3389/fonc.2016.00007 · Cited by 315 · see citing works

The p53-p21-DREAM-CDE/CHR pathway regulates G 2 /M cell cycle genes

Fischer, M., Quaas, M., Steiner, L., & Engeland, K. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv927 · Cited by 324 · see citing works

Synthetic Lethality of Combined Bcl-2 Inhibition and p53 Activation in AML: Mechanisms and Superior Antileukemic Efficacy

Pan, R., Ruvolo, V., Mu, H., Leverson, J. D., Nichols, G., Reed, J. C., Konopleva, M., & Andreeff, M. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.11.003 · Cited by 300 · see citing works

Cell-to-cell variation in p53 dynamics leads to fractional killing.

Paek, A. L., Liu, J. C., Loewer, A., Forrester, W. C., & Lahav, G. (2016) · Cell · doi:10.1016/j.cell.2016.03.025 · Cited by 292 · see citing works

The Molecular Balancing Act of p16INK4a in Cancer and Aging

LaPak, K. M., & Burd, C. E. (2013) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-13-0350 · Cited by 294 · see citing works

A Small Molecule RAS-Mimetic Disrupts RAS Association with Effector Proteins to Block Signaling

Divakar, S. K. A., Carpio, R. V., Dutta, K., Baker, S. J., Cosenza, S. C., Basu, I., Gupta, Y. K., Reddy, M. V. R., Ueno, L. A., Hart, J. R., et al. (2016) · Cell · doi:10.1016/j.cell.2016.03.045 · Cited by 278 · see citing works

miR-34: from bench to bedside

Agostini, M., & Knight, R. A. (2014) · Oncotarget · doi:10.18632/oncotarget.1825 · Cited by 254 · see citing works

KDM4A Lysine Demethylase Induces Site-Specific Copy Gain and Rereplication of Regions Amplified in Tumors

Black, J. C., Manning, A. L., Rechem, C. V., Kim, J., Ladd, B., Cho, J., Pineda, C. M., Murphy, N., Daniels, D. L., Montagna, C., et al. (2013) · Cell · doi:10.1016/j.cell.2013.06.051 · Cited by 214 · see citing works

The MYCN Protein in Health and Disease

Ruiz-Pérez, M. V., Henley, A. B., & Arsenian‐Henriksson, M. (2017) · Genes · doi:10.3390/genes8040113 · Cited by 181 · see citing works

Cellular senescence in the aging and diseased kidney

Valentijn, F. A., Falke, L. L., Nguyen, T. Q., & Goldschmeding, R. (2018) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-017-0434-2 · Cited by 173 · see citing works

Single molecule analysis of transcription factor binding at transcription sites in live cells

Morisaki, T., Müller, W., Golob, N., Mazza, D., & McNally, J. (2014) · Nature Communications · doi:10.1038/ncomms5456 · Cited by 167 · see citing works

The role of DNA damage responses in p53 biology

Speidel, D. (2015) · Archives of Toxicology · doi:10.1007/s00204-015-1459-z · Cited by 165 · see citing works

Mechanisms Regulating Protein Localization

Bauer, N. C., Doetsch, P. W., & Corbett, A. H. (2015) · Traffic · doi:10.1111/tra.12310 · Cited by 160 · see citing works

The transcription factor p53: Not a repressor, solely an activator.

Fischer, M., Steiner, L., & Engeland, K. (2014) · Cell Cycle · doi:10.4161/15384101.2014.949083 · Cited by 153 · see citing works

First-passage time approach to controlling noise in the timing of intracellular events

Ghusinga, K. R., Dennehy, J. J., & Singh, A. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1609012114 · Cited by 120 · see citing works

USP7 Is a Master Regulator of Genome Stability

Valles, G. J., Bezsonova, I., Woodgate, R., & Ashton, N. W. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00717 · Cited by 114 · see citing works

Mitotic catastrophe and cancer drug resistance: A link that must to be broken

Denisenko, T. V., Sorokina, I. V., Gogvadze, V., & Zhivotovsky, B. (2016) · Drug Resistance Updates · doi:10.1016/j.drup.2015.11.002 · Cited by 108 · see citing works

Screening for E3-Ubiquitin ligase inhibitors: challenges and opportunities

Landré, V., Rotblat, B., Melino, S., Bernassola, F., & Melino, G. (2014) · Oncotarget · doi:10.18632/oncotarget.2431 · Cited by 105 · see citing works

MAPK signaling cascades mediate distinct glucocorticoid resistance mechanisms in pediatric leukemia.

Jones, C. L., Gearheart, C. M., Fosmire, S., Delgado-Martín, C., Evensen, N. A., Bride, K. L., Waanders, A., Pais, F. M., Wang, J.-H., Bhatla, T., et al. (2015) · Blood · doi:10.1182/blood-2015-04-639138 · Cited by 110 · see citing works

Methyl Jasmonate: Putative Mechanisms of Action on Cancer Cells Cycle, Metabolism, and Apoptosis

Cesari, I. M., Carvalho, É., Rodrigues, M. F., Mendonça, B. D. S., Amoêdo, N. D., & Rumjanek, F. D. (2014) · International Journal of Cell Biology · doi:10.1155/2014/572097 · Cited by 101 · see citing works

p53 pulses lead to distinct patterns of gene expression albeit similar DNA-binding dynamics

Hafner, A., Stewart-Ornstein, J., Purvis, J. E., Forrester, W. C., Bulyk, M. L., & Lahav, G. (2017) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.3452 · Cited by 94 · see citing works

p53-dependent gene repression through p21 is mediated by recruitment of E2F4 repression complexes

Benson, E. K., Mungamuri, S. K., Attie, O., Kracikova, M., Sachidanandam, R., Manfredi, J. J., & Aaronson, S. A. (2013) · Oncogene · doi:10.1038/onc.2013.378 · Cited by 95 · see citing works

Cell-to-Cell Heterogeneity in p38-Mediated Cross-Inhibition of JNK Causes Stochastic Cell Death

Miura, H., Kondo, Y., Matsuda, M., & Aoki, K. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.08.020 · Cited by 85 · see citing works

Vascular aging: Molecular mechanisms and potential treatments for vascular rejuvenation

Mistriotis, P., & Andreadis, S. T. (2017) · Ageing Research Reviews · doi:10.1016/j.arr.2017.05.006 · Cited by 88 · see citing works

Dose and Schedule Determine Distinct Molecular Mechanisms Underlying the Efficacy of the p53–MDM2 Inhibitor HDM201

Jeay, S., Ferretti, S., Holzer, P., Fuchs, J., Chapeau, E. A., Wartmann, M., Sterker, D., Romanet, V., Murakami, M., Kerr, G., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-0338 · Cited by 87 · see citing works

The molecular activity of cannabidiol in the regulation of Nrf2 system interacting with NF-κB pathway under oxidative stress

Atalay, S., Gęgotek, A., & Skrzydlewska, E. (2022) · Redox Biology · doi:10.1016/j.redox.2022.102489 · Cited by 85 · see citing works

Cellular Senescence and the Kidney: Potential Therapeutic Targets and Tools

Knoppert, S. N., Valentijn, F. A., Nguyen, T. Q., Goldschmeding, R., & Falke, L. L. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00770 · Cited by 88 · see citing works

Sirtuin 7 promotes cellular survival following genomic stress by attenuation of DNA damage, SAPK activation and p53 response

Kiran, S., Oddi, V., & Ramakrishna, G. (2014) · Experimental Cell Research · doi:10.1016/j.yexcr.2014.11.001 · Cited by 82 · see citing works

Pre-clinical evaluation of the MDM2-p53 antagonist RG7388 alone and in combination with chemotherapy in neuroblastoma

Chen, L., Rousseau, R. F., Middleton, S. A., NICHOLS, G. L., Newell, D. R., Lunec, J., & Tweddle, D. A. (2015) · Oncotarget · doi:10.18632/oncotarget.3504 · Cited by 80 · see citing works

Bioinformatics analysis of the serine and glycine pathway in cancer cells

Antonov, A. V., Agostini, M., Morello, M., Minieri, M., Melino, G., & Amelio, I. (2014) · Oncotarget · doi:10.18632/oncotarget.2668 · Cited by 80 · see citing works

Integrin α5β1 and p53 convergent pathways in the control of anti-apoptotic proteins PEA-15 and survivin in high-grade glioma

Renner, G., Janoušková, H., Noulet, F., Koenig, V., Guérin, É., Bär, S., Nüesch, J. P. F., Rechenmacher, F., Neubauer, S., Kessler, H., et al. (2015) · Cell Death and Differentiation · doi:10.1038/cdd.2015.131 · Cited by 78 · see citing works

Inhibition of WIP1 phosphatase sensitizes breast cancer cells to genotoxic stress and to MDM2 antagonist nutlin-3

Pecháčková, S., Burdová, K., Benada, J., Kleiblová, P., Jeníková, G., & Macůrek, L. (2016) · Oncotarget · doi:10.18632/oncotarget.7363 · Cited by 75 · see citing works

The Growing Complexity of Cancer Cell Response to DNA-Damaging Agents: Caspase 3 Mediates Cell Death or Survival?

Mirzayans, R., Andrais, B., Kumar, P., & Murray, D. L. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17050708 · Cited by 74 · see citing works

Overexpression of SIRT1 Promotes High Glucose–Attenuated Corneal Epithelial Wound Healing via p53 Regulation of the IGFBP3/IGF-1R/AKT Pathway

Wang, Y., Zhao, X., Shi, D., Chen, P., Yu, Y., Yang, L., & Xie, L. (2013) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.13-12091 · Cited by 72 · see citing works

Comparative analysis of the microRNA transcriptome between yak and cattle provides insight into high-altitude adaptation

Guan, J., Long, K., Ma, J., Zhang, J., He, D., Jin, L. G., Tang, Q., Jiang, A., Wang, X., Hu, Y., et al. (2017) · PeerJ · doi:10.7717/peerj.3959 · Cited by 69 · see citing works

The p53 protein and its molecular network: Modelling a missing link between DNA damage and cell fate

Eliaš, J., Dimitrio, L., Clairambault, J., & Natalini, R. (2013) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2013.09.019 · Cited by 69 · see citing works

MYCN Impact on High-Risk Neuroblastoma: From Diagnosis and Prognosis to Targeted Treatment

Bartolucci, D., Montemurro, L., Raieli, S., Lampis, S., Pession, A., Hrelia, P., & Tonelli, R. (2022) · Cancers · doi:10.3390/cancers14184421 · Cited by 65 · see citing works

At a Crossroads to Cancer: How p53-Induced Cell Fate Decisions Secure Genome Integrity

Rizzotto, D., Englmaier, L., & Villunger, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910883 · Cited by 66 · see citing works

Significance of Wild-Type p53 Signaling in Suppressing Apoptosis in Response to Chemical Genotoxic Agents: Impact on Chemotherapy Outcome

Mirzayans, R., Andrais, B., Kumar, P., & Murray, D. L. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18050928 · Cited by 64 · see citing works

Targeting senescent retinal pigment epithelial cells facilitates retinal regeneration in mouse models of age-related macular degeneration

Chae, J., Jang, H., Son, C., Park, C., Choi, H., Jin, S., Lee, H., Lee, H., Ryu, J., Kim, N., et al. (2021) · GeroScience · doi:10.1007/s11357-021-00457-4 · Cited by 63 · see citing works

Pneumococcal Pneumolysin Induces DNA Damage and Cell Cycle Arrest

Rai, P., He, F., Kwang, J., Engelward, B. P., & Chow, V. T. K. (2016) · Scientific Reports · doi:10.1038/srep22972 · Cited by 62 · see citing works

Manipulating DNA damage-response signaling for the treatment of immune-mediated diseases

McNally, J. P., Millen, S. H., Chaturvedi, V., Lakes, N., Terrell, C. E., Elfers, E. E., Carroll, K. R., Hogan, S. P., Andreassen, P. R., Kanter, J., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1703683114 · Cited by 62 · see citing works

p53 partial loss-of-function mutations sensitize to chemotherapy

Klimovich, B., Merle, N., Neumann, M. M., Elmshäuser, S., Nist, A., Mernberger, M., Kazdal, D. N., Stenzinger, A., Timofeev, O. N., & Stiewe, T. (2021) · Oncogene · doi:10.1038/s41388-021-02141-5 · Cited by 61 · see citing works

p53-mediated suppression of BiP triggers BIK-induced apoptosis during prolonged endoplasmic reticulum stress

López, I., Tournillon, A.-S., Martins, R. P., Karakostis, K., Malbert-Colas, L., Nylander, K., & Fåhræus, R. (2017) · Cell Death and Differentiation · doi:10.1038/cdd.2017.96 · Cited by 61 · see citing works

Targeting negative regulation of p53 by MDM2 and WIP1 as a therapeutic strategy in cutaneous melanoma

Wu, C., Esfandiari, A., Ho, Y.-H., Wang, N., Mahdi, A. K., Aptullahoğlu, E., Lovat, P. E., & Lunec, J. (2017) · British Journal of Cancer · doi:10.1038/bjc.2017.433 · Cited by 62 · see citing works

P53 enhances apoptosis induced by doxorubicin only under conditions of severe DNA damage

Lin, R., Ho, C.-J., Chen, H.-W., Pao, Y., Chen, L.-E., Yang, M.-C., Huang, S., Wang, S., Chen, C., & Wang, C. (2018) · Cell Cycle · doi:10.1080/15384101.2018.1520565 · Cited by 60 · see citing works

Life and Death Decision-Making by p53 and Implications for Cancer Immunotherapy

Liu, Y. U., Leslie, P. L., & Zhang, Y. (2020) · Trends in cancer · doi:10.1016/j.trecan.2020.10.005 · Cited by 60 · see citing works

Inhibiting the Pkm2/b-catenin axis drives in vivo replication of adult cardiomyocytes following experimental MI

Hauck, L., Dadson, K., Chauhan, S., Grothe, D., & Billia, F. (2020) · Cell Death and Differentiation · doi:10.1038/s41418-020-00669-9 · Cited by 59 · see citing works

Cell cycle regulation and apoptosis mediated by p53 in response to hypoxia in hepatopancreas of the white shrimp Litopenaeus vannamei

Nuñez-Hernandez, D. M., Félix-Portillo, M., Peregrino-Uriarte, A. B., & Yepiz-Plascencia, G. M. (2017) · Chemosphere · doi:10.1016/j.chemosphere.2017.09.131 · Cited by 57 · see citing works

Inhibition of Wild-Type p53-Expressing AML by the Novel Small Molecule HDM2 Inhibitor CGM097

Weisberg, E., Halilovic, E., Cooke, V. G., Nonami, A., Ren, T., Sanda, T., Simkin, I., Yuan, J., Antonakos, B., Barys, L., et al. (2015) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-15-0429 · Cited by 56 · see citing works

Role of sirtuins in chronic obstructive pulmonary disease

Chun, P. (2014) · Archives of Pharmacal Research · doi:10.1007/s12272-014-0494-2 · Cited by 55 · see citing works

Roles of TP53 in determining therapeutic sensitivity, growth, cellular senescence, invasion and metastasis

McCubrey, J. A., Lertpiriyapong, K., Fitzgerald, T. L., Martelli, A. M., Cocco, L., Rakus, D., Gizak, A., Libra, M., Cervello, M., Montalto, G., et al. (2016) · Advances in Biological Regulation · doi:10.1016/j.jbior.2016.10.001 · Cited by 52 · see citing works

Determinants of p53 DNA binding, gene regulation, and cell fate decisions

Fischer, M., & Sammons, M. A. (2024) · Cell Death and Differentiation · doi:10.1038/s41418-024-01326-1 · Cited by 51 · see citing works

Hypoxia drives apoptosis independently of p53 and metallothionein transcript levels in hemocytes of the whiteleg shrimp Litopenaeus vannamei

Félix-Portillo, M., Martínez-Quintana, J. A., Arenas-Padilla, M., Mata‐Haro, V., Gómez‐Jiménez, S., & Yepiz-Plascencia, G. M. (2016) · Chemosphere · doi:10.1016/j.chemosphere.2016.07.041 · Cited by 51 · see citing works

Molecular hybridization design and synthesis of novel spirooxindole-based MDM2 inhibitors endowed with BCL2 signaling attenuation; a step towards the next generation p53 activators

Lotfy, G., Aziz, Y. M. A., Said, M. M., Ashry, E. S. H. E., Tamany, E. S. H. E., Abu-Serie, M. M., Teleb, M., Dömling, A. S. S., & Barakat, A. (2021) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2021.105427 · Cited by 51 · see citing works

Activation of p53 pathway by Nutlin-3a inhibits the expression of the therapeutic target α5 integrin in colon cancer cells

Janoušková, H., Ray, A., Noulet, F., Lelong-Rebel, I. H., Choulier, L., Schaffner, F., Lehmann, M., Martin, S., Teisinger, J., & Dontenwill, M. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.03.018 · Cited by 49 · see citing works

Collaborator of ARF (CARF) Regulates Proliferative Fate of Human Cells by Dose-dependent Regulation of DNA Damage Signaling

Cheung, C., Singh, R., Kalra, R. S., Kaul, S. C., & Wadhwa, R. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.547208 · Cited by 47 · see citing works

p53 dynamics orchestrates with binding affinity to target genes for cell fate decision

Wu, M., Ye, H., Tang, Z., Shao, C., Lu, G., Chen, B., Yang, Y., Wang, G., & Hao, H. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.492 · Cited by 49 · see citing works

Helping the released guardian: Drug combinations for supporting the anticancer activity of HDM2 (MDM2) antagonists

Kocik, J., Machula, M., Wisniewska, A., Surmiak, E., Holak, T. A., & Skalniak, L. (2019) · Cancers · doi:10.3390/cancers11071014 · Cited by 46 · see citing works

HER2-Targeted Tyrosine Kinase Inhibitors Cause Therapy-Induced-Senescence in Breast Cancer Cells

McDermott, M. S. J., Conlon, N. T., Browne, B. C., Szabo, A., Synnott, N. C., O’Brien, N. A., Duffy, M. J., Crown, J. P., & O’Donovan, N. (2019) · Cancers · doi:10.3390/cancers11020197 · Cited by 45 · see citing works

Modelling the onset of senescence at the G1/S cell cycle checkpoint

Mombach, J. C., Bugs, C. A., & Chaouiya, C. (2014) · BMC Genomics · doi:10.1186/1471-2164-15-s7-s7 · Cited by 45 · see citing works

Metabolomics–Proteomics Combined Approach Identifies Differential Metabolism-Associated Molecular Events between Senescence and Apoptosis

Wu, M., Ye, H., Shao, C., Zheng, X., Li, Q., Wang, L., Zhao, M., Lu, G., Chen, B., Zhang, J., et al. (2017) · Journal of Proteome Research · doi:10.1021/acs.jproteome.7b00111 · Cited by 45 · see citing works

The role of microRNA-34 family in Alzheimer’s disease: A potential molecular link between neurodegeneration and metabolic disorders

Bazrgar, M., Khodabakhsh, P., Prudencio, M., Mohagheghi, F., & Ahmadiani, A. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105805 · Cited by 44 · see citing works

Inhibiting MDM2-p53 Interaction Suppresses Tumor Growth in Patient-Derived Non–Small Cell Lung Cancer Xenograft Models

Hai, J., Sakashita, S., Allo, G., Ludkovski, O., Ng, C., Shepherd, F. A., & Tsao, M. (2015) · Journal of Thoracic Oncology · doi:10.1097/jto.0000000000000584 · Cited by 44 · see citing works

Is p53 Involved in Tissue‐Specific Insulin Resistance Formation?

Strycharz, J., Drzewoski, J., Szemraj, J., & Śliwińska, A. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/9270549 · Cited by 44 · see citing works

MDM4/HIPK2/p53 cytoplasmic assembly uncovers coordinated repression of molecules with anti-apoptotic activity during early DNA damage response

Mancini, F. R., Pieroni, L., Monteleone, V., Lucà, R., Fici, L., Luca, E., Urbani, A., Xiong, S., Soddu, S., Masetti, R., et al. (2015) · Oncogene · doi:10.1038/onc.2015.76 · Cited by 42 · see citing works

p53 Regulates the Expression of LRP1 and Apoptosis through a Stress Intensity-Dependent MicroRNA Feedback Loop

Leslie, P. L., Franklin, D. A., Liu, Y. U., & Zhang, Y. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.07.010 · Cited by 41 · see citing works

Design, Synthesis, Chemical and Biochemical Insights Into Novel Hybrid Spirooxindole-Based p53-MDM2 Inhibitors With Potential Bcl2 Signaling Attenuation

Aziz, Y. M. A., Lotfy, G., Said, M. M., Ashry, E. S. H. E., Tamany, E. S. H. E., Soliman, S. M., Abu-Serie, M. M., Teleb, M., Sammer Yousuf, B., Dömling, A. S. S., et al. (2021) · Frontiers in Chemistry · doi:10.3389/fchem.2021.735236 · Cited by 42 · see citing works

BOREAS: a global, phase III study of the MDM2 inhibitor navtemadlin (KRT-232) in relapsed/refractory myelofibrosis

Verstovsek, S., Al-Ali, H. K., Mascarenhas, J., Perkins, A., Vannucchi, A. M., Mohan, S. R., Scott, B. L., Woszczyk, D., Koschmieder, S., García-Delgado, R., et al. (2022) · Future Oncology · doi:10.2217/fon-2022-0901 · Cited by 41 · see citing works

The dynamics of p53 in single cells: physiologically based ODE and reaction–diffusion PDE models

Eliaš, J., Dimitrio, L., Clairambault, J., & Roberto Natalini, D. (2014) · Physical Biology · doi:10.1088/1478-3975/11/4/045001 · Cited by 41 · see citing works

Pharmacological targeting of p53 through RITA is an effective antitumoral strategy for malignant pleural mesothelioma

Marzo, D. D., Forte, I. M., Indovina, P., Gennaro, E. D., Rizzo, V., Giorgi, F. D., Mattioli, E., Iannuzzi, C. A., Budillon, A., Giordano, A., et al. (2013) · Cell Cycle · doi:10.4161/cc.27546 · Cited by 40 · see citing works

Caspase-3 and RasGAP: a stress-sensing survival/demise switch

Khalil, H., Bertrand, M. J. M., Vandenabeele, P., & Widmann, C. (2013) · Trends in Cell Biology · doi:10.1016/j.tcb.2013.08.002 · Cited by 40 · see citing works

Stochastic transcription in the p53‐mediated response to DNA damage is modulated by burst frequency

Friedrich, D., Friedel, L., Finzel, A., Herrmann, A., Preibisch, S., & Loewer, A. (2019) · Molecular Systems Biology · doi:10.15252/msb.20199068 · Cited by 40 · see citing works

The Pharmacodynamics of the p53-Mdm2 Targeting Drug Nutlin: The Role of Gene-Switching Noise

Puszyński, K., Gandolfi, A., & d’Onofrio, A. (2014) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1003991 · Cited by 39 · see citing works

A Model for p38MAPK-Induced Astrocyte Senescence

Mombach, J. C. M., Vendrusculo, B., & Bugs, C. A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0125217 · Cited by 39 · see citing works

A novel mathematical model of ATM/p53/NF- κB pathways points to the importance of the DDR switch-off mechanisms

Jonak, K., Kurpas, M. K., Szołtysek, K., Janus, P., Abramowicz, A., & Puszyński, K. (2016) · BMC Systems Biology · doi:10.1186/s12918-016-0293-0 · Cited by 39 · see citing works

Loss of Genome Fidelity: Beta HPVs and the DNA Damage Response

Wendel, S. O., & Wallace, N. A. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.02250 · Cited by 38 · see citing works

Propranolol Sensitizes Vascular Sarcoma Cells to Doxorubicin by Altering Lysosomal Drug Sequestration and Drug Efflux

Saha, J., Kim, J. H., Amaya, C. N., Witcher, C. M., Khammanivong, A., Korpela, D. M., Brown, D. R., Taylor, J., Bryan, B. A., & Dickerson, E. B. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2020.614288 · Cited by 39 · see citing works

Identification of novel radiation-induced p53-dependent transcripts extensively regulated during mouse brain development

Quintens, R., Verreet, T., Janssen, A., Neefs, M., Leysen, L., Michaux, A., Verslegers, M., Samari, N., Pani, G., Verheyde, J., et al. (2015) · Biology Open · doi:10.1242/bio.20149969 · Cited by 37 · see citing works

Cell Death Patterns Due to Warm Ischemia or Reperfusion in Renal Tubular Epithelial Cells Originating from Human, Mouse, or the Native Hibernator Hamster

Eleftheriadis, T., Pissas, G., Antoniadi, G., Liakopoulos, V., & Stefanidis, I. (2018) · Biology · doi:10.3390/biology7040048 · Cited by 37 · see citing works

MiR-35 buffers apoptosis thresholds in the C. elegans germline by antagonizing both MAPK and core apoptosis pathways

Tran, A., Chapman, E. M., Flamand, M. N., Yu, B., Krempel, S. J., Duchaîne, T. F., Eroglu, M., & Derry, W. B. (2019) · Cell Death and Differentiation · doi:10.1038/s41418-019-0325-6 · Cited by 37 · see citing works

Techniques for Studying Decoding of Single Cell Dynamics

Jeknić, S., Kudo, T., & Covert, M. W. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00755 · Cited by 37 · see citing works

Dying to Survive—The p53 Paradox

Lees, A., Sessler, T., & McDade, S. S. (2021) · Cancers · doi:10.3390/cancers13133257 · Cited by 37 · see citing works

Dual targeting of MDM2 and BCL2 as a therapeutic strategy in neuroblastoma

Goethem, A. V., Yigit, N., Moreno‐Smith, M., Vasudevan, S. A., Barbieri, E., Speleman, F., Shohet, J. M., Vandesompele, J., & Maerken, T. V. (2017) · Oncotarget · doi:10.18632/oncotarget.18982 · Cited by 36 · see citing works

Transcription-independent and -dependent p53-mediated apoptosis in response to genotoxic and non-genotoxic stress

Ho, C.-J., Lin, R., Zhu, W., Wen, T., Hu, C., Lee, Y.-L., Hung, T.-I., & Wang, C. (2019) · Cell Death Discovery · doi:10.1038/s41420-019-0211-5 · Cited by 35 · see citing works

Severe cellular stress drives apoptosis through a dual control mechanism independently of p53

Wang, Y.-C., Wang, L., Hung, T. I., Hong, Y., Chen, C., Ho, C.-J., & Wang, C. (2022) · Cell Death Discovery · doi:10.1038/s41420-022-01078-2 · Cited by 35 · see citing works

Involvement of dysregulated Wip1 in manganese-induced p53 signaling and neuronal apoptosis

Ma, X., Han, J., Wu, Q., Liu, H., Shi, S., Wang, C., Wang, Y., Xiao, J., Zhao, J., Jiang, J., et al. (2015) · Toxicology Letters · doi:10.1016/j.toxlet.2014.12.019 · Cited by 34 · see citing works

Bim directly antagonizes Bcl-xl in doxorubicin-induced prostate cancer cell apoptosis independently of p53

Yang, M.-C., Lin, R., Huang, S., Huang, S.-Y., Chen, W., Wang, S., Hong, Y., & Wang, C. (2015) · Cell Cycle · doi:10.1080/15384101.2015.1127470 · Cited by 34 · see citing works

Dying to protect: cell death and the control of T‐cell homeostasis

Li, K., Shanmuganad, S., Carroll, K. R., Katz, J. D., Jordan, M. B., & Hildeman, D. A. (2017) · Immunological Reviews · doi:10.1111/imr.12538 · Cited by 34 · see citing works

DNA Damage Stress: Cui Prodest?

Verma, N., Franchitto, M., Zonfrilli, A., Cialfi, S., Palermo, R., & Talora, C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20051073 · Cited by 31 · see citing works

Snoopy’s hybrid simulator: a tool to construct and simulate hybrid biological models

Herajy, M., Liu, F., Röhr, C., & Monika Heiner, A. (2017) · BMC Systems Biology · doi:10.1186/s12918-017-0449-6 · Cited by 31 · see citing works

Molecular Mechanism for Selective Cytotoxicity towards Cancer Cells of Diselenide-Containing Paclitaxel Nanoparticles

Li, J., Gu, Y., Zhang, W., Bao, C., Li, C., Zhang, J., Liu, T., Li, S., Huang, J., Xie, Z., et al. (2019) · International Journal of Biological Sciences · doi:10.7150/ijbs.34878 · Cited by 31 · see citing works

Nutlin-Induced Apoptosis Is Specified by a Translation Program Regulated by PCBP2 and DHX30

Rizzotto, D., Zaccara, S., Rossi, A., Galbraith, M. D., Andrysík, Z., Pandey, A., Sullivan, K. D., Quattrone, A., Espinosa, J. M., Dassi, E., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.03.011 · Cited by 27 · see citing works

The light subunit of mushroom Agaricus bisporus tyrosinase: Its biological characteristics and implications

Ismaya, W. T., Tandrasasmita, O. M., Sundari, S., Diana, D., Lai, X., RETNONINGRUM, D. S., Dijkstra, B. W., Tjandrawinata, R. R., & Rachmawati, H. (2017) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2017.04.014 · Cited by 31 · see citing works

Residual apoptotic activity of a tumorigenic p53 mutant improves cancer therapy responses

Timofeev, O. N., Klimovich, B., Schneikert, J., Wanzel, M., Pavlakis, E., Noll, J., Mutlu, S., Elmshäuser, S., Nist, A., Mernberger, M., et al. (2019) · The EMBO Journal · doi:10.15252/embj.2019102096 · Cited by 31 · see citing works

Abstract A53: Dose-dependent levels of p53 mediate different cell fate decisions in human mammary epithelial cells

Kracikova, M., Akiri, G., Geroge, A., Sachidanandam, R., & Aaronson, S. A. (2009) · Cancer Research · doi:10.1158/0008-5472.fbcr09-a53

Apoptosis - the p53 network

Haupt, S., Berger, M., Goldberg, Z., & Haupt, Y. (2003) · Journal of Cell Science · doi:10.1242/jcs.00739 · Cited by 1,136 · see citing works

The p53 tumour suppressor gene: a mediator of a G1 growth arrest and of apoptosis

Yonish-Rouach, E. (1996) · Cellular and Molecular Life Sciences · doi:10.1007/bf01920109 · Cited by 68 · see citing works

A question of life or death: the p53 tumor suppressor gene.

Yonish-Rouach, E. (1997) · PubMed · Cited by 13 · see citing works

p53 dynamics orchestrates with binding affinity to target genes for cell fate decision

Wu, M., Ye, H., Tang, Z., Shao, C., Lu, G., Chen, B., Yang, Y., Wang, G., & Hao, H. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.492 · Cited by 49 · see citing works